Intratumoral Expression Level of Epidermal Growth Factor Receptor and Cytokeratin 5/6 Is Significantly Associated With Nodal and Distant Metastases in Patients With Basal-like Triple-Negative Breast Carcinoma-Reference-Cited by-同舟云学术

Intratumoral Expression Level of Epidermal Growth Factor Receptor and Cytokeratin 5/6 Is Significantly Associated With Nodal and Distant Metastases in Patients With Basal-like Triple-Negative Breast Carcinoma

Published:2010-11 Issue:5 Volume:134 Page:782-787
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:Am J Clin Pathol

Author:

Sutton Lisa M.,Han Jeong S.,Molberg Kyle H.,Sarode Venetia R.,Cao Dengfeng,Rakheja Dinesh,Sailors Joseph,Peng Yan

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/134/5/782/5004439/ajcpath134-0782.pdf

Reference26 articles.

1. Rakha E Reis-Filho JS . Basal-like breast carcinoma, from expression profiling to routine practice. Arch Pathol Lab Med. 2009;133:860–867.

2. Prognostic markers in triple-negative breast cancer

3. Differences in breast carcinoma characteristics in newly diagnosed African–American and Caucasian patients

4. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA

5. Triple negative breast cancers: Clinical and prognostic implications

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological features of breast cancer progression: From DCIS to invasive ductal carcinoma;2023-10-10

2. Expression of the Immunohistochemical Markers CK5, CD117, and EGFR in Molecular Subtypes of Breast Cancer Correlated with Prognosis;Diagnostics;2023-01-19

3. Varying outcomes of triple-negative breast cancer in different age groups–prognostic value of clinical features and proliferation;Breast Cancer Research and Treatment;2022-10-19

4. Varying outcomes of triple-negative breast cancer in different age groups - prognostic value of clinical features and proliferation;2022-08-08

5. Assessment of Epithelial to Mesenchymal Transition Markers in Breast Carcinoma and its Association with Histopathological Grading, Size and Metastasis;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2022